Vitamin B12 deficiency schilling test: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(4 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Vitamin B12 deficiency}}
==Overview==
'''Step 1: '''One µg of radioactive crystalline B12 is taken orally. '''Step 2: '''Gastric acid and pepsin free vitamin B12 from food proteins. This step is not required when crystalline B12 is utilized as the test dose. B12 attaches to "R" binders (R) produced by the stomach, which have a higher affinity for B12 than intrinsic factor (IF), also produced by the stomach. '''Step 3: '''Pancreatic proteases degrade the "R" binders, allowing formation of the B12-IF complex, the specific form absorbed by the terminal ileum. '''Step 4: '''One hour after the test dose, a 1000 µg "flushing" dose of non-radioactive B12 is given to saturate B12 binders (transcobalamin). '''Step 5:'''If present, bacteria in "blind loops" in the duodenum or jejunum preferentially utilize vitamin B12, allowing none to be available at the site of absorption. '''Step 6: '''With blood and tissue B12 binding sites blocked by the "flushing" dose, the B12/IF complex is absorbed by the terminal ileum, and the B12 is excreted in the urine (step 7), which is assayed for its content of radioactivity. The test can be repeated with the addition of missing factors (eg, intrinsic factor, pancreatic extract), or following the use of nonabsorbable antibiotics (blind loops and/or bacterial overgrowth present), or gluten-free diet (celiac disease). 
 
==Schilling Test==
The Schilling test is used to diagnose the site of the disorder causing cobalamin deficiency.
 
=== phase 1: oral vitamin B<sub><small>12</small></sub> and intramuscular vitamin B<sub><small>12</small></sub> ===
Patient is taken 1 µg of radioactive B12 orally  then  An intramuscular injection of unlabeled vitamin B<sub><small>12</small></sub> is given an hour later. Single  intramuscular  injection is given due to temporarily saturate B<sub><small>12</small></sub> receptors in the liver with  to prevent radioactive vitamin B<sub><small>12</small></sub> binding in body tissues (especially in the liver),  if it  absorbed from the G.I. tract, it will pass into the urine. The patient's urine is collected over the next 24 hours to assess the absorption.<ref name="pmid21900461">{{cite journal |vauthors=MacFarlane AJ, Greene-Finestone LS, Shi Y |title=Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey |journal=Am. J. Clin. Nutr. |volume=94 |issue=4 |pages=1079–87 |date=October 2011 |pmid=21900461 |doi=10.3945/ajcn.111.020230 |url=}}</ref>
 
Normally, the ingested radiolabeled vitamin B<sub><small>12</small></sub> will be absorbed into the body. Since the body already has liver receptors for transcobalamin/vitamin B<sub><small>12</small></sub> saturated by the injection, much of the ingested vitamin B<sub><small>12</small></sub> will be excreted in the urine.
* A normal result shows '''at least 10%''' of the radiolabeled vitamin B<sub><small>12</small></sub> in the urine over the first 24 hours.
* In patients with pernicious anemia or with deficiency due to impaired absorption, '''less than 10%''' of the radiolabeled vitamin B<sub><small>12</small></sub> is detected.
The normal test will result in a higher amount of the radiolabeled cobalamin in the urine because it would have been absorbed by the intestinal epithelium, but passed into the urine because all hepatic B12 receptors were occupied. An abnormal result is caused by less of the labeled cobalamin to appear in the urine because it will remain in the intestine and be passed into the feces.
 
=== Phase  2: vitamin B<sub><small>12</small></sub> and intrinsic factor ===
If  B12 in the urine is  low , the test is repeated, this time with additional oral intrinsic factor.
* If this second urine collection is normal, this shows a lack of intrinsic factor production. This is by definition pernicious anemia.
* A low result on the second test implies abnormal intestinal absorption (malabsorption), which is due to  coeliac disease, biliary disease, Whipple's disease, small bowel bacterial overgrowth syndrome, fish tapeworm infestation (Diphyllobothrium latum), or liver disease. Malabsorption of B<sub><small>12</small></sub> can be caused by intestinal dysfunction from a low vitamin level in-and-of-itself (see below), causing test result confusion if repletion has not been done for some days previously
 
=== Phase 3: vitamin B<sub><small>12</small></sub> and antibiotics ===
Useful for identifying patients with bacterial overgrowth syndrome.


Note: While the Schilling test is rarely used today, steps 2, 3, and 6, as described above, delineate the normal pathway for B12 absorption.
=== Phase 4: vitamin B<sub><small>12</small></sub> and pancreatic enzymes ===
In this phase pancreatic enzymes are administered, useful to identifying patients with pancreatitis
{| class="wikitable"
{| class="wikitable"
|Test
|Test
Line 50: Line 69:


• Results depend upon the length of resection or the extent of disease. Values will not normalize with >100 cm of resection. Values may normalize after treatment of active Crohn's disease. 
• Results depend upon the length of resection or the extent of disease. Values will not normalize with >100 cm of resection. Values may normalize after treatment of active Crohn's disease. 
==Overview==
==Schilling Test==


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Primary care]]
{{WH}}
{{WS}}

Latest revision as of 00:42, 30 July 2020

Overview

Schilling Test

The Schilling test is used to diagnose the site of the disorder causing cobalamin deficiency.

phase 1: oral vitamin B12 and intramuscular vitamin B12

Patient is taken 1 µg of radioactive B12 orally  then An intramuscular injection of unlabeled vitamin B12 is given an hour later. Single intramuscular injection is given due to temporarily saturate B12 receptors in the liver with  to prevent radioactive vitamin B12 binding in body tissues (especially in the liver), if it absorbed from the G.I. tract, it will pass into the urine. The patient's urine is collected over the next 24 hours to assess the absorption.[1]

Normally, the ingested radiolabeled vitamin B12 will be absorbed into the body. Since the body already has liver receptors for transcobalamin/vitamin B12 saturated by the injection, much of the ingested vitamin B12 will be excreted in the urine.

  • A normal result shows at least 10% of the radiolabeled vitamin B12 in the urine over the first 24 hours.
  • In patients with pernicious anemia or with deficiency due to impaired absorption, less than 10% of the radiolabeled vitamin B12 is detected.

The normal test will result in a higher amount of the radiolabeled cobalamin in the urine because it would have been absorbed by the intestinal epithelium, but passed into the urine because all hepatic B12 receptors were occupied. An abnormal result is caused by less of the labeled cobalamin to appear in the urine because it will remain in the intestine and be passed into the feces.

Phase 2: vitamin B12 and intrinsic factor

If B12 in the urine is low , the test is repeated, this time with additional oral intrinsic factor.

  • If this second urine collection is normal, this shows a lack of intrinsic factor production. This is by definition pernicious anemia.
  • A low result on the second test implies abnormal intestinal absorption (malabsorption), which is due to coeliac disease, biliary disease, Whipple's disease, small bowel bacterial overgrowth syndrome, fish tapeworm infestation (Diphyllobothrium latum), or liver disease. Malabsorption of B12 can be caused by intestinal dysfunction from a low vitamin level in-and-of-itself (see below), causing test result confusion if repletion has not been done for some days previously

Phase 3: vitamin B12 and antibiotics

Useful for identifying patients with bacterial overgrowth syndrome.

Phase 4: vitamin B12 and pancreatic enzymes

In this phase pancreatic enzymes are administered, useful to identifying patients with pancreatitis

Test Gastrectomy, pernicious anemia Celiac disease* Bacterial overgrowth Ileal resection or disease• Pancreatic insufficiency
Vitamin B12 Low Low Low Low/normal Low
Vitamin B12 + intrinsic factor Normal Low Low Low/normal Low
Vitamin B12 + antibiotics n/a Low Normal Low/normal Low
Vitamin B12 + gluten-free diet n/a Normal n/a Low/normal Low
Vitamin B12 + pancreatic enzymes n/a n/a n/a n/a Normal

* The Schilling test may be normal in patients with celiac disease because the terminal ileum is frequently spared. n/a, these stages of the Schilling test are not needed for the disorder. 

• Results depend upon the length of resection or the extent of disease. Values will not normalize with >100 cm of resection. Values may normalize after treatment of active Crohn's disease. 

References

  1. MacFarlane AJ, Greene-Finestone LS, Shi Y (October 2011). "Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey". Am. J. Clin. Nutr. 94 (4): 1079–87. doi:10.3945/ajcn.111.020230. PMID 21900461.

Template:WH Template:WS